C.R. I. Phase I

CRI Phase I is a clinical research organization (CRO) based in Miami, Florida, that specializes in early-phase clinical trials. Established in 2012, the company was formed when Dr. Hugo Romeu acquired the Miami clinical facility of PRACS Institute, a move that preserved the site's extensive history in clinical pharmacology. The company provides a full suite of Phase I services, including first-in-human trials, bioequivalence studies, and bioavailability testing for the biopharmaceutical and medical device industries. CRI Phase I operates a high-capacity clinical research center in the Golden Glades Office Park, supported by a team of veteran investigators and clinical staff.